Drug Repurposing in the Development of Anticancer Agents

Current Medicinal Chemistry
Sureyya Olgen, Lakshmi P Kotra

Abstract

Research into repositioning known drugs to treat cancer other than the originally intended disease continues to grow and develop, encouraged in part, by several recent success stories. Many of the studies in this article are geared towards repurposing generic drugs because additional clinical trials are relatively easy to perform and the drug safety profiles have previously been established. This review provides an overview of anticancer drug development strategies which is one of the important areas of drug restructuring. Repurposed drugs for cancer treatments are classified by their pharmacological effects. The successes and failures of important repurposed drugs as anticancer agents are evaluated in this review. Drugs could have many off-target effects, and can be intelligently repurposed if the off-target effects can be employed for therapeutic purposes. In cancer, due to the heterogeneity of the disease, often targets are quite diverse, hence a number of already known drugs that interfere with these targets could be deployed or repurposed with appropriate research and development.

References

Oct 28, 1972·Lancet·G J GasicS Murphy
Oct 1, 1980·Journal of the National Cancer Institute·G D Friedman, H K Ury
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Apr 5, 2001·Trends in Parasitology·P L OlliaroY Yuthavong
Apr 12, 2001·The Journal of Biological Chemistry·J A KeiferA S Baldwin
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono
Jan 31, 2002·Annual Review of Medicine·Marco E Turini, Raymond N DuBois
Jul 19, 2003·Molecular Pharmacology·Thomas EfferthJens Oliver Funk
Aug 3, 2004·Nature Reviews. Drug Discovery·Ted T Ashburn, Karl B Thor
Nov 2, 2004·Nature Reviews. Cancer·Paolo MoniniBarbara Ensoli
Jan 8, 2005·Medicinal Research Reviews·Roman A BlahetaJindrich Cinatl
Feb 17, 2006·Genes & Development·Oliver H KrämerThorsten Heinzel
Jan 5, 2007·Journal of the National Cancer Institute·Patricia F CooganLynn Rosenberg
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kwang Seok AhnBharat B Aggarwal
Apr 17, 2007·ACS Chemical Biology·Curtis R ChongJun O Liu
Nov 30, 2007·Current Pharmaceutical Design·Martin MichaelisJindrich Cinatl
Jan 31, 2008·Leukemia & Lymphoma·Lillian P Burke, Cynthia A Kukoly
Aug 30, 2008·Therapeutics and Clinical Risk Management·Teru HideshimaKenneth C Anderson
Aug 30, 2008·Therapeutics and Clinical Risk Management·Thomas J Polascik, Vladimir Mouraviev
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Christine Galustian, Angus Dalgleish
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sao JiralerspongAna M Gonzalez-Angulo
Jul 8, 2009·Bioorganic & Medicinal Chemistry·M SimunovićE Pontiki
Mar 20, 2010·Diabetes Care·Michael BodmerChristoph R Meier
Mar 27, 2010·International Journal of Cell Biology·Cyril SobolewskiMarc Diederich
May 7, 2010·Cell Metabolism·Adem KalenderGeorge Thomas
Aug 4, 2010·Journal of Hematology & Oncology·Clara Hwang, Elisabeth I Heath
Aug 28, 2010·Journal of Biomedicine & Biotechnology·Sébastien ChateauvieuxMarc Diederich
Sep 3, 2010·Cancer Prevention Research·Kunihiro HosonoAtsushi Nakajima
Sep 17, 2010·Gut·Farhat V N DinMalcolm G Dunlop
Feb 25, 2011·Cancer Letters·Verena Jendrossek
Jun 30, 2011·Briefings in Bioinformatics·Christos AndronisAris Persidis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.